.png)
Agenzia Italiana del Farmaco
AIFA: further investigations needed on second booster dose of COVID-19 vaccines - AIFA: further investigations needed on second booster dose of COVID-19 vaccines
AIFA: further investigations needed on second booster dose of COVID-19 vaccines
AIFA's Technical and Scientific Committee (CTS) started on 24th March 2022 the evaluation of the opportunity of a second booster dose of COVID-19 vaccines for particular categories of subjects.
Considering all the available data, the CTS decided that further in-depth studies are necessary, integrating international scientific evidence with data from ongoing studies in Italy.
The CTS reiterated that the completion of the vaccination cycle followed by the already authorised booster dose is essential.
Published on: 24 March 2022
#AIFA promuove l’ascolto e la trasparenza
Approvati i Regolamenti di “AIFA Ascolta” e “AIFA Incontr...
Vai al post →
Oggi si celebra il #WorldAutismAwarenessDay.
🔵 L'Agenzia Italiana del Farmaco sostiene la Giornata...
Vai al post →
Jelena Ivanovic, dirigente medico dell’Ufficio Procedure Europee di #HTA di #AIFA, è stata eletta Co...
Vai al post →
Biosimilari: webinar AIFA su terzo Position Paper
La Commissione Scientifica ed Economica (CSE) di ...
Vai al post →
🎙️ Il Presidente #AIFA intervistato da @presadirettarai sulle false terapie a base di cellule stami...
Vai al post →
💛 28 marzo 2026 – Giornata Mondiale dell’Endometriosi 💛
#AIFA si illumina di giallo per accendere...
Vai al post →
